Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer

NCT00614653 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Bevacizumab
DRUG: Erlotinib
DRUG: Capecitabine
RADIATION: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]